[Inhibition of bone resorption by bisphosphonates, heterogeneous group of drugs with different intracellular model of action].
Stajszczyk
M
M
Klinika Chorób Wewnetrznych i Chemioterapii Onkologicznej Sl. AM w Katowicach. marcins(at)mp.pl
D019883:Alkyl and Aryl Transferases / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001862:Bone Resorption / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism*; D004164:Diphosphonates / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D051228:Geranyltranstransferase; D006801:Humans; D008798:Mevalonic Acid / Q000378:metabolism; D010010:Osteoclasts / Q000473:pathology; D017368:Protein Prenylation; D017027:Protein Tyrosine Phosphatases / Q000378:metabolism; D006180:Proton-Translocating ATPases / Q000378:metabolism
D004164:Diphosphonates; D019883:Alkyl and Aryl Transferases; D051228:Geranyltranstransferase; D017027:Protein Tyrosine Phosphatases; D006180:Proton-Translocating ATPases; D008798:Mevalonic Acid
Hamowanie resorpcji kości przez bifosfoniany, niejednorodna grupe leków o róznym wewnatrzkomórkowym mechanizmie działania.